Vimarsana
Biggest News Aggregation in the World

Page 6 - Dose Reduction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dose Reduction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dose Reduction Today - Breaking & Trending Today

Global Pediatric Imaging Technology Report 2022: Portable Mobile Imaging Devices, Technologies that Lower Dose Exposure, and the Use of AI and Gamification to Revolutionize the Market - Vimarsana News

Global Pediatric Imaging Technology Report 2022: Portable Mobile Imaging Devices, Technologies that Lower Dose Exposure, and the Use of AI and Gamification to Revolutionize the Market

Published: May 26, 2022

/PRNewswire/ -- The "Pediatric Imaging Technology Innovation and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study...

Source: prnewswire.com
Related Topics:
Laura WoodPediatric Imaging Technology InnovationPatient MovementLarge CompaniesTeleradiology SolutionsDevelopment Of Imaging Device ComponentsTechnology SegmentationGlobal Pediatric Imaging Networks For Remote ConsultationAi TechnologyTechnology Development To Maintaina Competitive EdgeOffice Hours CallResearch MethodologyDevelopment Of Mobile SystemsTechnology PartnershipsE St Office Hours CallCompanies Use PartnershipsComfortable Imaging TechnologyImaging Technology InnovationQuestions This Study AnswersTopics CoveredStrategic ImperativeFactors Creating PressureTop Three Strategic ImperativesPediatric ImagingOpportunities Fuel
Global Pediatric Imaging Technology Innovation and Market Growth Opportunities Report 2022: Development of Imaging Device Components and the Integration of AI/ML are the Focus - ResearchAndMarkets.com - Press Release - Vimarsana News

Global Pediatric Imaging Technology Innovation and Market Growth Opportunities Report 2022: Development of Imaging Device Components and the Integration of AI/ML are the Focus - ResearchAndMarkets.com - Press Release

Published: May 23, 2022

The "Pediatric Imaging Technology Innovation and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study highligh

Source: wiredprnews.com
Related Topics:
Global Pediatric Imaging Networks For Remote ConsultationPediatric Imaging Technology InnovationTechnology Development To Maintaina Competitive EdgeAi TechnologyPatient MovementResearch MethodologyTechnology PartnershipsDevelopment Of Mobile SystemsLarge CompaniesTeleradiology SolutionsCompanies Use PartnershipsDevelopment Of Imaging Device ComponentsComfortable Imaging TechnologyTechnology SegmentationImaging Technology InnovationQuestions This Study AnswersTopics CoveredStrategic ImperativeFactors Creating PressureTop Three Strategic ImperativesPediatric Imaging IndustryOpportunities FuelGrowth Pipeline EngineImaging InvolvesLow Radiation Doses
UCB Showcases Key Rheumatology Data at ACR Convergence 2021 - Vimarsana News

UCB Showcases Key Rheumatology Data at ACR Convergence 2021

Published: November 5, 2021

/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF...

Source: prnewswire.com
Related Topics:
Bruxelles CapitaleNicole HergaCertolizumab PegolJ Clin PharmacolAntje WitteHead Of Immunology Medical AffairsGroup Of CompaniesAmerican College Of Rheumatology ConvergenceDrug AdministrationTerm Improvements In HealthSource Ucb IncJeffrey StarkLong Term SafetyAnkylosing SpondylitisInterim Results AfterOngoing PhaseShows SustainedMeaningful Long Term ImprovementsHealth Related QualityPatient Reported Disease ActivityAnkylosing Spondylitis Receiving BimekizumabPost Hoc AnalysesPsoriatic ArthritisYear ResultsTumor Necrosis Factor Inhibitor
Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition - Vimarsana News

Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition

Published: November 4, 2021

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Source: prnewswire.com
Related Topics:
United StatesEltanexor MonotherapyPraneeth SudalaguntaSuresh Kumar BalasubramanianH Lee MoffittYuki NishidaMarie MaerevoetSrinivas TantravahiDarrell WhiteSuzanne LentzschWaldenstrom MacroglobulinemiaJatin ShahSangmin LeePiroska KlementPaula RodrSundar JagannathPaula RestrepoMuhamed BaljevicYael CohenNizar BahlisSelective Inhibitor Of Nuclear ExportColumbia University Irving Medical CenterCompany To Host Investor Day EventMount Sinai School Of MedicineJules Bordet Institute
Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition - Vimarsana News

Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition

Published: November 4, 2021

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Source: prnewswire.com
Related Topics:
United StatesEltanexor MonotherapyPraneeth SudalaguntaSuresh Kumar BalasubramanianH Lee MoffittYuki NishidaMarie MaerevoetSrinivas TantravahiDarrell WhiteSuzanne LentzschWaldenstrom MacroglobulinemiaJatin ShahSangmin LeePiroska KlementPaula RodrSundar JagannathPaula RestrepoMuhamed BaljevicYael CohenNizar BahlisSelective Inhibitor Of Nuclear ExportColumbia University Irving Medical CenterCompany To Host Investor Day EventMount Sinai School Of MedicineJules Bordet Institute